News from the “Regulatory Affairs & Drug Development” Master’s program

The program, which is offered during the winter semester and is supported and co-organized by AmI, is revised and expanded each year. Many of the instructors are employees of pharmaceutical companies, and in recent years, instructors from government agencies have joined the faculty. For the past two years, the interdisciplinary nature of the program has been further enhanced by an interdisciplinary lecture series led by pharmacists and medical professionals.